All lobbying filings
Dendreon Pharmaceuticals, LLC
Dendreon Pharmaceuticals, LLC filed a Q1 report for Dendreon Pharmaceuticals, LLC on May 6, 2025.
Lobbying for Dendreon Pharmaceuticals, LLC
Filing · LD-2 quarterly report
Q1 report
Reporting period
1st Quarter 2025
Jan 1 - Mar 31 · Posted May 6, 2025
Expenses
$60,147
What this organization spent lobbying with its own staff.
Reported using the LDA's own definitions (method A): the three
LDA methods count different costs, so an expenses figure is
not comparable across filers that used different ones.
Client based in
California
Government bodies contacted
2
Lobbying activity
1
Access to autologous cellular immunotherapies in Medicare Part B. Implementation of provisions included in Subtitle B of PL.117-169-Inflation Reduction Act of 2022.